IMC Chicago’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,210
| Closed | -$443K | – | 650 |
|
|
2024
Q1 | $443K | Buy |
25,210
+10,209
| +68% | +$179K | ﹤0.01% | 350 |
|
|
2023
Q4 | $271K | Buy |
+15,001
| New | +$271K | ﹤0.01% | 269 |
|
|
2022
Q4 | – | Sell |
-23,335
| Closed | -$590K | – | 226 |
|
|
2022
Q3 | $590K | Buy |
23,335
+2,332
| +11% | +$59K | ﹤0.01% | 153 |
|
|
2022
Q2 | $566K | Buy |
21,003
+2,335
| +13% | +$62.9K | ﹤0.01% | 166 |
|
|
2022
Q1 | $450K | Buy |
+18,668
| New | +$450K | ﹤0.01% | 205 |
|
|
2021
Q4 | – | Sell |
-27,459
| Closed | -$495K | – | 314 |
|
|
2021
Q3 | $495K | Buy |
27,459
+13,256
| +93% | +$239K | ﹤0.01% | 216 |
|
|
2021
Q2 | $261K | Buy |
14,203
+724
| +5% | +$13.3K | ﹤0.01% | 222 |
|
|
2021
Q1 | $304K | Buy |
13,479
+1,875
| +16% | +$42.3K | ﹤0.01% | 213 |
|
|
2020
Q4 | $273K | Buy |
+11,604
| New | +$273K | ﹤0.01% | 187 |
|